Bupropion and Naltrexone in Methamphetamine Use Disorder
- 13 January 2021
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 384 (2), 140-153
- https://doi.org/10.1056/nejmoa2020214
Abstract
The use of naltrexone plus bupropion to treat methamphetamine use disorder has not been well studied.Keywords
Funding Information
- U.S. Department of Health and Human Services (Contract No. HHSN271201500065C; HHSN271201400028C)
- National Institute on Drug Abuse (UG1DA020024; UG1DA013035; UG1DA040316; UG1DA013727)
This publication has 29 references indexed in Scilit:
- Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findingsDrug and Alcohol Dependence, 2013
- The Treatment Effectiveness Assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addictionSubstance Abuse and Rehabilitation, 2012
- Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trialsContemporary Clinical Trials, 2011
- Concise Associated Symptoms Tracking ScaleBritish Journal of Psychology, 2011
- Naltrexone for the Treatment of Amphetamine Dependence: A Randomized, Placebo-Controlled TrialAmerican Journal of Psychiatry, 2008
- An examination of the efficiency of the sequential parallel design in psychiatric clinical trialsClinical Trials, 2007
- Bupropion for the Treatment of Methamphetamine DependenceNeuropsychopharmacology, 2007
- Bupropion Reduces Methamphetamine-Induced Subjective Effects and Cue-Induced CravingNeuropsychopharmacology, 2005
- The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design ApproachPsychotherapy and Psychosomatics, 2003
- The PHQ-9Journal of General Internal Medicine, 2001